A detailed history of Time Scale Financial, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Time Scale Financial, Inc. holds 6,108 shares of MRNA stock, worth $225,079. This represents 0.16% of its overall portfolio holdings.

Number of Shares
6,108
Previous 6,108 -0.0%
Holding current value
$225,079
Previous $938,000 20.9%
% of portfolio
0.16%
Previous 0.21%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 18, 2022

SELL
$126.46 - $235.05 $2,276 - $4,230
-18 Reduced 0.29%
6,108 $1.05 Million
Q4 2021

Jan 19, 2022

BUY
$225.82 - $368.51 $1.37 Million - $2.24 Million
6,067 Added 10283.05%
6,126 $1.56 Million
Q1 2021

Apr 22, 2021

BUY
$109.18 - $185.98 $655 - $1,115
6 Added 11.32%
59 $8,000
Q4 2020

Jan 28, 2021

BUY
$65.74 - $169.86 $657 - $1,698
10 Added 23.26%
53 $6,000
Q3 2020

Oct 07, 2020

BUY
$54.34 - $94.85 $978 - $1,707
18 Added 72.0%
43 $3,000
Q2 2019

Jul 31, 2019

BUY
$13.7 - $28.34 $342 - $708
25 New
25 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Time Scale Financial, Inc. Portfolio

Follow Time Scale Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Time Scale Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Time Scale Financial, Inc. with notifications on news.